Get the content you want anytime you want.

Latest News From Contagion® Live

Latest News

GLS-5300 MERS CoV Vaccine Candidate Shows Promise in Phase 1 Trial
Investigators in the first human trial of a MERS-CoV candidate report strong immune responses and no serious adverse events, advancing the vaccine candidate to phase 1/2a and phase 2 trials.
Failures in Following Proper Urine Culture Practices
We're failing to make sure cultures are indicated properly in catheterized patients, which can lead to serious disruptions of care.
Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
Study to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine
The NIH-funded study will evaluate experimental adjuvants AF03 and Advax-CpG55.2 over an 18-month study period.
Preclinical Trial of TDF Vaginal Ring for PrEP Ends Early
Research on a tenofovir disoproxil fumarate intravaginal ring for PrEP hit a hurdle when 8 of 12 women unexpectedly developed vaginal ulcers.
Ebola Clinical Trial Halted in DRC
An independent monitoring board recommended early termination of the PALM trial after determining that 2 of the 4 experimental therapies were linked with better rates of survival.
The Continued Search for Optimal Daptomycin Dosing Strategies in VRE Bloodstream Infections
Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.
The ID Pipeline: FDA Activity From the Week of August 4, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of August 4, 2019.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?